Express Pharma
Home  »  Latest Updates  »  Piramal Pharma Solutions expands capacity for sterile manufacturing in Lexington

Piramal Pharma Solutions expands capacity for sterile manufacturing in Lexington

Read Article

The Lexington site capabilities and capacity would be expanded for commercial aseptic manufacturing

Piramal Pharma Solutions, a provider of sterile drug product development and manufacturing services, has announced plans for a $25 million expansion of its facilities in Lexington, Kentucky.

Piramal Pharma Solutions’ plan focuses on expanding the Lexington site capabilities and capacity for commercial aseptic manufacturing. This will be done by increasing vial filling capability and lyophilisation capacity, as well as upgrades to the associated facilities and utilities. Piramal’s Lexington site has a pipeline of products which are expected to be commercialised in the next three to five years.

Phase 1 of the expansion of the Lexington facility will add a new manufacturing suite including a high speed vial filling machine. Also as part of the first phase of expansion, Piramal will install a new isolator based vial filler in its existing manufacturing suite. Combined, the two fillers installed underphase I of the expansion will increase the company’s vial filling capabilities by more than five-fold. Phase 2 of the expansion will include the installation of two lyophilizers and are planned to integrate with the new filler line in the new manufacturing suite offering dedicated capacity for both potent and non-potent products

Vivek Sharma, CEO – Pharma Solutions, Piramal Enterprises, commented, “Since our initial investment the Kentucky site has demonstrated both leadership and growth, and we are pleased to announce this next phase of investment to enhance capability and capacity. We appreciate the active support from the State of Kentucky, the local government, and most importantly, the community, as we continue our growth plans in Lexington. The expansion in our capacity at Kentucky will help us better serve our customers who are looking for us to deliver solutions that will improve the standard of care.”

Bill Wedlake, President of Piramal Pharma Solutions Formulations Business added, “We are extremely excited to initiate this expansion and continue the company’s vision of becoming the premier aseptic manufacturing service provider that began with the acquisition of Coldstream Laboratories in January of 2015.”

Comments are closed.